Evaluation of the Neointimal Healing by OCT of the Tapered DES Biomime Morph (TAPER-I Study)

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

December 8, 2021

Study Completion Date

December 8, 2021

Conditions
Atherosclerosis
Interventions
DEVICE

Biomime Morph, a tapered drug eluting stent (DES) with hybrid design

Biomime Morph DES is a cobalt-chromium stent, with strut thickness of 65 µm, a hybrid cell design (closed cells in the extremity and open cells in the middle) and a conic shape, where the proximal part of the stent is 0.5 mm larger than the distal part (Table 1). In addition, the Biomime Morph elutes Sirolimus from a biodegradable polymer matrix.

Trial Locations (1)

05403-900

Instituto do Coração - HCFMUSP, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT04805619 - Evaluation of the Neointimal Healing by OCT of the Tapered DES Biomime Morph (TAPER-I Study) | Biotech Hunter | Biotech Hunter